SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank21
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-15.30
↓ 412% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
-2.99
Historical baseline
PeriodValueYoY Change
2025-15.30-642.5%
2024-2.06-161.4%
2023-0.79+28.8%
2022-1.11+73.2%
2021-4.14-50.2%
2020-2.75-599.4%
2019-0.39-1.2%
2018-0.39+47.4%
2017-0.74+66.8%
2016-2.22-